Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Whalen Kathleen M

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/1/2019

3. Issuer Name and Ticker or Trading Symbol

HCA Healthcare, Inc. [HCA]

(Last) (First) (Middle)

ONE PARK PLAZA

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
SVP & Chief Ethics Officer /

(Street)

NASHVILLE, TN 37203

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6871	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Right	⁽¹⁾	11/6/2023	Common Stock	1750	$45.30	D
Stock Appreciation Right	⁽²⁾	11/6/2023	Common Stock	2250	$45.30	D
Stock Appreciation Right	⁽³⁾	2/5/2024	Common Stock	2625	$47.97	D
Stock Appreciation Right	⁽⁴⁾	2/5/2024	Common Stock	2100	$47.97	D
Stock Appreciation Right	⁽⁵⁾	2/4/2025	Common Stock	5000	$68.96	D
Stock Appreciation Right	⁽⁶⁾	1/29/2026	Common Stock	3760	$69.58	D
Stock Appreciation Right	⁽⁷⁾	2/1/2027	Common Stock	4040	$81.96	D
Stock Appreciation Right	⁽⁸⁾	1/31/2028	Common Stock	5040	$101.16	D
Stock Appreciation Right	⁽⁹⁾	10/31/2028	Common Stock	13730	$133.53	D

Explanation of Responses:
(1)	The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014.
(2)	The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
(3)	The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
(4)	The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
(5)	The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
(6)	The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
(7)	The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.
(8)	The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.
(9)	The stock appreciation rights vest in four equal annual installments beginning on October 31, 2019.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Whalen Kathleen M ONE PARK PLAZA NASHVILLE, TN 37203			SVP & Chief Ethics Officer

Signatures
/s/ Virginia Chase Crocker, Attorney-in-Fact		1/10/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.